Tuan Anh Nguyen – BPharm, MPharm, PhD

Dr Tuan Anh Nguyen is an Australian NHMRC-ARC Dementia Research Development Fellow. After obtaining his PhD in public health and community medicine at the University of New South Wales in 2011, Tuan consolidated his research skills upon experience as a postdoctoral research fellow at School of Pharmacy and Medical Sciences, University of South Australia. He then taught health care management at School of Medicine, Flinders University before taking up his current fellowship.

Over the last five years, Tuan has attracted AUD 722,934 in research funding and has been a key researcher for other projects and consultancies worth AUD 252,500; has had 36 publications including two books and four book chapters; has had 11 conference presentations, three of which under guest speaker invitations. Tuan has been appointed to be a member of a number of national and international peak bodies and committees such as the Australian NHMRC National Institute for Dementia Research and the Sydney Southeast Asia Centre, University of Sydney. He was a convenor for the Generic Medicines Policies Workshop at the Asia Pacific Conference on National Medicines Policies 2012. Tuan has been invited and awarded seven scholarships to present his research at international conferences, and his PhD thesis has been published as a book by the World Health Organization.


BPharm – Hanoi University of Pharmacy – 1997
MPharm, double degree – Hanoi University of Pharmacy – 2000
PhD – University of New South Wales – 2011

Research interest

Neurodegenerative diseases with a focus on dementia and cognitive impairment
National medicine policy in low and middle income countries
Access to medicines
Quality use of medicines
Drug safety

Selected Research Projects

Development of a unified list of drugs associated with drug-induced cognitive impairment (2016 –
2019). Sponsor: Australian Government National Health and Medical Research Council – Australian
Research Council. Role: NHMRC-ARC Dementia Research Development Fellow – Principle

Use of medicines with anticholinergic and sedative effects in people with dementia in China and
Vietnam (2017-2018). Sponsor: China–Australia Centre for Health Sciences Research. Role: Principle

Access to essential medicines for older people in the Asia Pacific Region (2015-2016). Sponsor:
China–Australia Centre for Health Sciences Research. Role: Principle investigator
Medicine utilisation methods to support pharmaceutical policy implementation – The first step of
WHO/EMP work for improving medicine use in low and middle income countries (2015). Sponsor:
World Health Organization. Role: Co-investigator

Scoping study on models of the regulation of pharmaceutical promotion in the WPRO region
(Australia). Sponsor: Health Action International. Role: Principle investigator
International reference pricing policy in Vietnam in International reference pricing: An extended
guidebook to the new global pharmaceutical pricing paradigm (2014). Sponsor: IHS Life Sciences –
United Kingdom. Role: Principle investigator

Examination of barriers and facilitators to achieving quality use of medicines along the continuum of
care (2012). ). Sponsor: SA Health. Role: Co-investigator

Medicine price survey in Vietnam (2005). Sponsor: World Health Organization. Role: Principle

Selected publications


Vitry A, Nguyen TA, Baer B, Bhushan A, Tisocki K, Roughead EE (2016). Older people’s access to
medicines and assistive devices in the Western Pacific Region. WHO Regional Office for the Western
Pacific. ISBN: 9789290617839.

Nguyen TA (2011). Medicine prices and pricing policies in Vietnam. World Health Organization.
Book chapters

Nguyen TA, Roughead EE (2017). Strength and weaknesses of pharmaceutical policy in relation to
rational and responsible medicines use. In: Mohamed Ibrahim MI, Babar Z, Wertheimer AI, editor.
Social and Administrative Aspects of Pharmacy in Developing Countries: Present Challenges and
Future Solutions. Elsevier Inc, The Netherlands. ISBN: 978-0-12-811228-1.

Nguyen TA, Vitry A, Roughead EE (2017). Pharmaceutical policy in Vietnam. In: Babar Z, editor.
Pharmaceutical Policy in Countries with Developing Healthcare Systems. pp 75-94. ADIS – Springer
International Publishing, Switzerland. doi: 10.1007/978-3-319-51673-8. ISBN: 978-3-319-51672-1.

Nguyen TA, Roughead EE (2015). Pharmaceutical pricing policies in Vietnam. In: Babar Z, editor.
Pharmaceutical Prices in the 21st Century. pp 321-342. Springer International Publishing,
Switzerland. ISBN 978-3-319-12169-7

Nguyen TA, Knight R, Mant A, Brooks G, Razee H (2013). ‘Informal payments’ and high medicine
prices in Vietnam – A qualitative study. In: Suwandono A, Kamil S, Chalid P, Irwansyah, Ginting J,
Wulandari R, editor. The Role of Educators & Students in Building Integrity. pp 639-658. Tiri –
Integrity Action, Indonesia. ISBN: 978-602-18666-4-1

Journal articles

Kassie GM, Kalisch Ellett LM, Nguyen TA, Roughead EE (2017). Knowledge of Australian hospital
pharmacists regarding delirium in elderly patients. Journal of Pharmacy Practice and Research (in

Wang H, Qiang S, Vitry A, Nguyen TA (2017). Availability, prices and affordability of selected
essential medicines for chronic diseases in 11 countries of the Asia Pacific Region: a secondary
analysis. Asia Pacific Journal of Public Health. https://doi.org/10.1177/1010539517700472.

Nguyen TA, Knight R, Mant A, Husna R, Brooks G, Dang TH, Roughead EE (2017). Inflated
Medicine Prices in Vietnam: A Qualitative Study. Health Policy and Planning. doi:

Roughead EE, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai ECC, Man KKC, Nguyen
TA, Ooba N, Park BJ, Sato T, Shin JY, Wang TT, Griffiths J, Wong ICK, Yang YHK, Pratt NL
(2016). Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using
sequence symmetry analysis. Expert Opinion On Drug Safety.

Nguyen TA, Gilmartin JFM, Tan ECK, O’Donnell LK, Ellett LK, Reeve E (2016). The impact of
pharmacist interventions on quality use of medicines, quality of life and health outcomes in people
with dementia and cognitive impairment: a systematic review and meta-analysis. PROSPERO
2016:CRD42016046492 Available from

Gilmartin J, Nguyen TA, Reeve E, Tan ECK (2016). Incorporating research into current pharmacy
practice: the future of Australian pharmacy? Journal of Pharmacy Practice and Research. doi:
10.1002/jppr.1249. 46(4): 397-8.

Roughead EE, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai ECC, Man KKC, Nguyen
TA, Ooba N, Park BJ, Sato T, Shin JY, Wang TT, Griffiths J, Wong ICK, Yang YHK, Pratt NL
(2015). Variation in association between thiazolidinediones and heart failure across ethnic groups:
Retrospective analysis of large healthcare claims databases in six countries. Drug Safety, 38:823–831.

Vitry A, Nguyen TA, Entwistle V, Roughead E (2015). Regulatory withdrawal of medicines
marketed with uncertain benefits: the bevacizumab case study. Journal of pharmaceutical policy and
practice. 8:25. doi: 10.1186/s40545-015-0046-2.

Nguyen TA, Caughey GE, Pratt N, Shakib S, Kemp A, Roughead EE (2015). Hospitalisation for
drug-induced hepatotoxicity: linking Y codes with pharmaceutical claims data to identify implicated
medicines. Journal of Clinical Pharmacy and Therapeutics. doi: 10.1111/jcpt.12249.

Pratt NL, Ramsay EN, Kalisch Ellett LM, Nguyen TA, Roughead EE (2015). Association between
ophthalmic timolol and hospitalisation for bradycardia. Journal of Ophthalmology (Special issue on
Aging eye). doi: 10.1155/2015/567387.

Nguyen TA, Knight R, Roughead EE, Brooks G, Mant A (2014). Policy options for pharmaceutical
pricing and purchasing: issues for low- and middle-income countries. Health Policy and Planning.

Vitry AI, Nguyen TA, Ramsay EN, Caughey GE, Gilbert AL, Shakib S, Ryan P, Esterman A,
McDermott RA, Roughead EE (2014). General practitioner management plans delaying time to next
potentially preventable hospitalization for patients with heart failure. Internal Medicine.

Pratt NL, Ramsay EN, Kalisch Ellett LM, Nguyen TA, Barratt JD, Roughead EE (2014). Association
between use of multiple psychoactive medicines and hospitalisation for falls: Retrospective analysis
of a large healthcare claim database. Drug Safety, 37:529–535. doi: 10.1007/s40264-014-0179-2.

Hassali MA, Alrasheedy AA, McLachlan A, Nguyen TA, AL-Tamimi SK, Ibrahim MIM, Aljadhey H
(2014). The experiences of implementing generic medicines policy in eight countries: a review and
recommendations for a successful promotion of generic medicines use. Saudi Pharmaceutical
Journal. http://dx.doi.org/10.1016/j.jsps.2013.12.017.

Nguyen TA, Hassali MA, McLachlan A (2013). Generic medicines policies in Asia Pacific Region:
Ways forward. WHO South-East Asia Journal of Public Health, 2 (1): 72-74.
Nguyen AT, Knight R, Mant A, Cao QM, Brooks G (2010). Medicine pricing policies: Lessons from
Vietnam. Southern Med Review, 3 (2): 12-19.

Nguyen AT, Knight R, Mant A, Cao QM, Auton M (2009). Medicine prices, availability, and
affordability in Vietnam. Southern Med Review, 2 (2): 2-9.